Tag Archives: transfusion bag
2015, global medical equipment market reached $ 228 billion
U.S. market research firm MarketsandMarkets latest published market research report – \"the world\\ s 10 major categories of medical equipment market\" (GlobalTop10MedicalDevicesMarket) predicts that by 2015, 10 categories of medical devices worldwide market will reach $ 228 billion, from 2010 2015 compound annual growth rate during the period 6.8%.
The 10 categories of medical devices for cardiovascular diseases equipment, orthopedic devices, diagnostic imaging equipment, low attack equipment, diabetes equipment, anesthesia / respiratory care equipment, dialysis equipment, ophthalmic equipment, patient monitoring equipment, and medical diagnostic equipment station.
Report that, as with the cardiovascular, respiratory, oncology and related diseases such as nervous system has become increasingly common, the market will need for faster and better medical facilities for treatment and diagnostic purposes.
Last year, the 10 categories of medical devices worldwide market size of 164 billion dollars.
Internet of Things technology for intelligent medical field convenience
The future work of intelligent wireless medical monitoring technology can achieve, and significantly raised reflect a high degree of sharing of medical resources, reduce public health costs.
Recently, the Information Office of the Ministry of Health deputy Rengao Yan Jie said: from the application program, the main things is through the application of the formation of China\\ s electronic health care system, services for the medical field to bring the four facilities.
First, through the electronic medical and RFID technology can make things a lot of work to implement wireless medical monitoring of the application, can be significantly high degree of sharing, and reduce the public health care costs. Through the Internet of Things technology can provide remote medical care to the people and self-care, our health care is indeed a shortage of resources, but also there is the irrational and wasteful application of the phenomenon, we must, through the application of things, so that there is a fundamental medical model of change. Some do not have to take up physical resources to the hospital for the disease and its information can be collected in advance by the things the patient can self-care through telemedicine can make a big difficult cases through telemedicine technology is a good treatment.
Things in the health sector through the application, or to emphasize the timely collection and to achieve a high degree of information sharing, thereby enhancing the health of modern service standards.
How things can bring new medical services and facilities it, we talked things through remote monitoring of chronic disease sustainable, some conventional old age, like the \"three high\" and so on, can sense the information technology timely collection, you can effectively monitor chronic diseases. Acute infectious disease through real-time monitoring to control the spread of the disease.
We can through health monitoring, including ECG, ultrasonic, etc. can directly interface to dynamic real-time patient information. Also consider the management of the patient to try. Management of the patient\\ s treatment, including two-way track, from home to hospital, home from the hospital, which involves high-end hospitals to community hospitals from the track; including for the management of maternal and child identification, not only for the safety of mother and child, but also maternal and child health care quality and health to be monitored; of dementia patients and the elderly have to do RFID and Internet of Things technology for comprehensive care and management.
Second, the current through the technology of things to act on the medical management field, including the management of hospital assets, including blood management, medical waste management, and management of hospitals sterile, these are technical and we application of a combination of things made in health development application direction and planning.
Pharmaceutical production and food production, these are every day issues, food safety and drug safety is related to social stability and people\\ s safety. Through complex networking technology to implement the production process, market liquidity and the patient\\ s full range of drug testing. Through the Internet of Things technology to form the whole of the production, distribution, use of monitoring and the monitoring of things and the patient\\ s electronic case together to form a comprehensive security of medication and treatment management.
Their applications for medical care, including laboratory and building intelligent so some of the specific position, but also pointed out the direction and requirements. Laboratory, the technology to achieve things through intelligent operating room, through the building automation and building control to ensure the safety of the hospital environment; other wireless networking applications mobile technology is the focus of the field, mobile care, moving rounds, including mobile ECG acquisition.
Third, the things and the construction of hospital information, and any new technology must be applied prior to organically combine to sustainable development, we have to take things past the traditional hospital technology and information technology combined organic up, which involves telemedicine and network construction by Lai Puhui through physical networking technology to help patients in remote areas is difficult to see a doctor to solve their problems, to provide communication and application platform, including the convenience fee and on-line real-time diagnostics, online pathological analysis, and equipment interoperability and so on.
Through the implementation of things your family\\ s safety monitoring, the patient can get a variety of real-time information, such as the patient\\ s body temperature in real-time acquisition. Our treatment of patients in the hospital, we try to achieve through things technology more humane health care, we not only have a good plan, but also with other countries on international exchanges, two days ago with my counterparts in Singapore During the exchange, when people say they have advocated non-interference for the treatment of patients, patients in the hospital in time, every morning, the day check the temperature several times, often too difficult for patients to wake up to the test table They have adopted labeling technology for interference-free measuring body temperature, this technology also gives us a good insight.
Through complex networking technology to the hospital and often prone to problems where the quality and safety management, including hospitals, home-made agents for the treatment and the whole process of management.
Chinese medicine is also the motherland\\ s cultural treasures, how to make modern scientific medicine, but also by things like heat, pulse collection is also studied.
Fourth, through things for the monitoring of bacteria in the air, the earthquake in Japan is also very important lesson to us, we want things technology through real-time detection of the environment, but also through the Internet of Things technology for monitoring body temperature, as well as transmission important indicator of disease to be monitored. Also for the control of infectious diseases caused by livestock to prevent escape, the establishment of \"anti-escape system.\"
Emergency command and emergency preparedness of the medical programs available through the things a good disaster response system, through the implementation of networking technology to the disaster site medical data collection, including the interconnection of various medical devices, especially because of secondary disasters caused by the disaster, through the unity of things to achieve on-site scheduling of resources, whether it is a disaster are inseparable from the explosion of the epidemic and the health sector. Through complex networking technology to achieve a full range of command and control and medical monitoring equipment, to form the things of the emergency response system.
Things in the patient\\ s safety is not just planning, but also pilot the past few years in the State Golden Card Project Information Office has proposed a unified, coordinated planning, beginning this year should pay attention to some of the demonstration focused on the application, including hospitals applications and public health monitoring applications, which also includes things which label supplies and electronic monitoring, operation monitoring, and laboratory laboratory monitoring, so that the construction of information technology, especially information technology to the hospital wireless and intelligent. And the management of community people, drugs, back, and things of intelligent operating room management and monitoring.
Gao Jie said, things set up working group on standards has started to work, has had several meetings, some companies and organizations participated in the standards working groups. This work will continue to carry out. Through the application of things to promote health care quality improvement, and promote a high degree of sharing of medical resources, improve the health of urban and rural social security system for health care reform to provide a new type of network support platform.
U S Launches New Mercury Visage MR MRI receivers
According to reports, U.S. mercury computer system recently developed a breakthrough in magnetic resonance imaging (mri) receivers visage mr, greatly improving the image quality and reduced scan time.
The device is a high-bandwidth, 16 – bit similar to the digital receiver, with advanced digital filtering and noise reduction technology mri-specific, compared with other systems, can significantly improve a letter mr images – noise ratio (snrs), than the current use of mri receiver four times higher resolution, the sample also has a very high processing speed.
It is understood, mercury is a global business technology optimization (bto) software and services leader. mercury is a strong leader with excellent company. Since its inception in 1989, mercury, company market share, revenue and provide value to customers and so continued to grow steadily.
Use of Xbox development came hand movements Restorer
New Jersey, New American continent published by Rutgers University, Faculty of Engineering of the University to use Microsoft s Xbox console has developed a hand motor recovery with exercise equipment, which will be used as a result of physical disabilities caused by stroke patients.
Hand movements Restorer
This exercise equipment is the Xbox console and the glove-type game device "EssentialRealityP5Glove" composed of relatively cheap. Glove-type device the user will set the game in hand, through the subtle finger movements to operate the game screen, in order to achieve recovery training purposes.
So far the recovery appliances are generally higher than the price, and the birth of this new recovery appliance although slightly less accuracy and function, but the cost is only $ 600 for small clinics, personal home use.
Medical equipment to the large European market leveraging substantial
Level of economic development in Europe is higher than the continents, the medical device market is relatively mature, relatively speaking, with the exception of Albania, Bulgaria and a few other countries, other European countries, a good industrial base, the higher the level of hospital equipment. Europe is not only medical device industry is well developed, but also the world\\ s leading medical device market.
According to foreign data show that in 2010, the global medical device market, total sales of approximately € 184.9 billion (equivalent to more than 23 billion U.S. dollars), of which about 30% in Europe, 553 million euros, after the United States is the world\\ s first second largest medical device market. Germany, France, Britain, Italy and Switzerland, the European medical device market, together accounting for 76% of the medical device market, while other European countries, the total medical device market, only the remaining 1 / 4 share. This reflects the European medical device market is highly intensive.
CE certification is a stepping stone
Many of China\\ s current domestic medical device manufacturers have products into the European market will, but most domestic manufacturers of the situation in Europe is poorly understood.
Depending on the classification of medical devices, the EU has been issued three directives on medical devices, in order to coordinate the European medical device product management practices. The world of medical device manufacturers want their products into the European market must follow the above requirements. These three products access to the medical device directives are: Active Implantable Medical Devices Directive (AIMDD, 90/335/EEC), Medical Devices Directive (MDD, 93/42/EEC) and in vitro diagnostic devices directive ( IVDD, 98/79EEC).
In the above three instructions to the second Directive (MDD) of the widest application, including almost all the exports of China\\ s medical device products, such as sanitation materials and medical dressings, medical catheters, breathing machine, various types of endoscopes and patient monitors and so on.
To develop the domestic manufacturers in Europe, the EU must be CE certification, which is exported to the EU market access to medical products qualification. It is understood that manufacturers must be in accordance with ISO13460 and other quality control production line of new provisions, in order to achieve the production level of market acceptance in Europe, and that the EU will from time to time send personnel on-site inspection. EU medical device product quality assurance system is the implementation of more stringent EN46001, which issued in the EU are detailed in Appendix MDD implementing rules and regulations, China\\ s manufacturers and should be carefully studied with reference to the requirement of production. So far, there are over 100 enterprises in China issued by the European Union CE certification. CE certification issued by the equivalent of U.S. FDA 510 (K) regulations. But generally speaking, in the EU market of medical products faster rate than the United States.
Proposal to open up Europe
However, even if has been CE certification, it does not guarantee that the product can be quickly available in Europe. Foreign firms in the EU CE certification later, how to successfully enter the European market? For this problem, the United States Cleveland Medical Device Industry Association, Mr. Paz made some suggestions, a good reference and learning:
First, with the large amount of the major European procurement director of medical doctors in hospitals to make friends, so they understand your product and become familiar with. Because only first obtain a large hospital trust, small hospitals will be attracted.
Second, find product agents in European countries is also a good way. If the company small, economic strength is not strong, then you want a shortcut to enter the European market only to find a local agent who. If you can find a reliable agent in Europe, means that the product has entered the European market gates.
Third, if a higher price, then it must be in Germany, France, Britain, Italy and Switzerland and other European countries, important clinical trials of medical products.
Not recognized by doctors in Europe and outside Europe countries are doing clinical trials, they believe the hospital made famous European clinical trial results. Enterprises must be prepared to do clinical trials in Europe, funding preparation. This investment is worth it, once the product in Europe, the economic return is considerable.
Fourth, the small product should look for distributors in Europe. If exports are relatively low economic value of health materials, medical dressings and low-cost low-end products such as disposable syringes, it might be the product directly by the European distributor sales throughout Europe, so that they share some profits.
Related>>> EU regulatory legislation reforming Yixie
As the legal framework for the complex and can not follow up on emerging technologies and regulations of the Member States in the lack of uniformity in the implementation process and other reasons, the EU regulatory rules by the multi-Yi Xie blamed.
In 2007, the EU issued a directive Yixie regulatory rules changes, and implemented in 2010. The directive adds Yixie pre-market monitoring requirements, increased demand for some of the clinical data standards, and will be added to Yixie medical software list. In addition, in May 1, the national authorities (NCA) has been asked to the European medical device database (EUDAMED) to submit the relevant product certification, pre-market clinical investigations and monitoring data. The database can only be accessed by NCA and the European Commission, aims to streamline the listing process Yi Xie. Prior to this, the new Yixie must be individually listed to inform members of the various target markets, and now you can save this step.
Despite all these changes, Yi Xie regulatory rules are still faced with various criticisms. November 2010, the European Commission published a directive to modify its schedule Yi Xie and Yi Xie rewrite the EU Directive 2012 legislative agenda as the first step.
So far, rewritten Yixie instructions not yet finalized the details of the proposal. Commission announced the schedule did not give a specific reform plan, but added to provide a range of possible options, including a wider range of commands to replace the MDD and AIMDD, issued a directive to upgrade to replace the existing IVDD, by conformity assessment procedures will streamline and clarify the key concepts and terminology and other ways to promote consistency between the EEA countries.
Accordance with the schedule and is expected to begin in the first quarter of 2012, the implementation of the revised Yixie instructions. However, the European Commission has so far not provided the final reform bill deadline, the final regulations will be rewritten and the European Union Council of the European Parliament by the audits.
Domestic medical device production batch made difficult by small-scale use of equipment
As a rapidly developing economy of Guangdong province, how to reduce injury, traffic injury mortality and morbidity, it is worth attention. I learned yesterday from Southern Medical University, has set up 10 years of trauma treatment center, Guangdong province has been covered a total of 11 prefecture-level cities of more than 40 units, most of which are primary health care sector.
86-year-old Chinese Academy of Engineering, Southern Medical University Zhong Shizhen shuttle 10 years to lead the team in Dongguan, Jiangmen, Huizhou and other primary hospitals, not only to promote wound treatment technology, but also to encourage grass-roots based on clinical need to create a first-line treatment of invasive medical devices.
However, due to strict approval process, which made access difficult to obtain approval of medical devices, to market. According to Zhong Shizhen said, the hospital\\ s medical equipment in use today, the vast majority are still imported, the domestic price is about four times.
10 years of service dozens of primary health care sector
Zhong Shizhen anatomy of modern clinical experts. About 10 years ago, Guangdong injury, the incidence of traffic injuries Renqun very high, and Technology Department has put a lot of research funds to the construction of platform, technology, and the effect is not large. In this context, trauma treatment center set up Guangdong Province, Zhong Shizhen director, would like to use advanced technology to medical institutions for the first-line treatment of trauma services.
After 10 years, Zhong Shizhen in the province with the \"walk\", Huizhou, Dongguan, Shantou, Jiangmen city\\ s primary health care institutions as well as some of the top three major hospitals in Guangzhou, one after another to participate in the trauma treatment center. So far, a total of 11 prefecture-level city in which more than 40 units.
Zhong Shizhen introduction, the center covers the provincial Science and Technology Department of Medical Biomechanics Laboratory and Key Laboratory of organization building and testing and other institutions, can provide a solid front-line clinical specialist technology platform. \"Every place has its own circumstances and advantages, we will make professional recommendations, and guide them to play to strengths.\"
Not only that, Zhong Shizhen also apply for research funding to help grass-roots units. According to Zhong Shizhen said, relying on the center has several units which apply to the provincial research funding and published papers, not long ago, a sum of 600,000 yuan of funds fall into the center of some units of the successful \"pocket\", wound treatment equipment for research .
Only small-scale domestic use of medical devices
Zhong Shizhen said that more than 40 primary trauma care platform has accumulated a lot of clinical experience, some of the first-line according to clinical manufacturing medical devices, such as rehabilitation equipment. \"This is a meaningful thing can be said now Jiucheng surgical instruments are imported, so too lose and we will translate into economic benefits of medical theory, the application of bio-mechanical knowledge and a solid theoretical foundation came up with independent intellectual property rights medical equipment, but the authorities concerned for approval is too harsh, not to the lot and our equipment is inferior in accuracy may be imported equipment, but the price of imported equipment of 1 / 4. \"
The most typical case of Guangdong Province from the slave injury treatment center. Zhong Shizhen said, \"They had the equipment for injury rehabilitation, mostly imported, a set down more than 40 million by the center\\ s medical theories to support, and special research project, they successfully created their own product, price 10 million on the line, and the results were not worse than abroad, but I could not get the production batch number, the result can only use a small range. similar situation exists in other primary hospitals. \"
Some people on the domestic concerns about the effect of medical devices. Zhong Shizhen said, to verify the equipment is easy to use, there are mature technologies, \"We have testers, through index analysis can determine the new equipment compared to the original model is an improvement, whether the effect on patients.\" Zhong Shizhen appeal, there must be a more reasonable approval process, so that people made as soon as possible to spend affordable medical equipment.
Zhong Shizhen:
Hand surgeons can hope that the unemployment
Nanfang Daily: This year you are 86 years old, ten years to do that you have personally grassroots levels?
Zhong Shizhen: I have been to more than 40 units, at least examine their condition, they also go to listing. I found the site visits, they widespread problem, the level is uneven. Primary health care institutions to become a specialist or center of the bottom of the base, we provide technical support, for us, the lack of a large number of clinical cases, such cooperation can complement each other.
Nanfang Daily: Guangdong in recent years the number of traumatic changes in the situation?
Zhong Shizhen: With the improvement of labor rights protection, the downward trend in the number of injuries, but there is an upward trend in traffic injuries, although Jin Mo, played an important role, however, the number of traffic casualties remained high. According to related statistics, Guangzhou, nearly five years (2009-2010) from 55 055 traffic accidents, injured 61,924 people, killed 9031 people, ranking the city the first comprehensive economic losses of nearly 10 billion.
Nanfang Daily: With the promotion of wound treatment platform, you have any specific vision?
Zhong Shizhen: This is a serious public health problem, which restricts social development, and hope the injured could receive timely and effective treatment to reduce losses. For example, the high number of hand injuries, I hope that the unemployed can hand surgeon, so much the better.
Immuno-gene therapy on a new era of health care
World Health Organization has defined the tumor as a chronic disease can be controlled, comprehensive treatment of the tumor is the best way. 254 Hospital of Tianjin experts Tan Zhuren said biological treatment center, cancer immuno-gene therapy in improving survival of patients treated, extended periods of time, "survival zone" has a unique advantage, the production of immune gene therapy for cancer treatment or rehabilitation on a new era.
How to treat cancer?
Surgery, radiotherapy, chemotherapy is the three modes of cancer treatment, side effect in reducing tumor burden significantly. 254 Hospital of Tianjin Medical Center experts Tan Zhuren said biological, bio-based research and development, promotion of bio-technology, especially breakthroughs in cancer immuno-gene therapy. Now, the immune gene therapy has become the fourth largest cancer treatment patterns. Immuno-gene therapy of tumor cells in the small clearing to prevent tumor recurrence and metastasis in excellent results. So now the use of surgery, radiotherapy, chemotherapy and other methods at the same time, the use of immuno-gene therapy, to achieve the optimal effect of cancer treatment, that is, the integrated use of surgery, chemotherapy and immuno-gene therapy is a cancer treatment solution.
Immune gene therapy effective? How to evaluate the effectiveness of immuno-gene therapy?
Immuno-gene therapy refers to the person s own immune cells by extracting, after laboratory induced culture, genetically modified transplanted into the body, designed to achieve tumor kill effect. So how does the effectiveness of this treatment? Tan Zhuren that the clinical efficacy of the immune gene therapy that is effective, and patient tumor type, stage, the individual case, the chosen type of immune cells, giving the number of cells, channels, frequency, and many other factors are related; In addition, Evaluation of the efficacy of immunotherapy is still no uniform standards and methods are seriously hampered the efficacy of immunotherapy accurate and objective evaluation. Tumor-specific immune therapy in addition to the evaluation of tumor size and the need to observe changes in the number (reduced, unchanged or increased), but also the need for evaluation of immune-related indicators, such as whether to have a tumor-specific T-cell immune response, These tumor-specific T cells to specifically kill tumor cells is a function of whether the tumor killing effect of changes in tumor size and number of associated and so on.
Immuno-gene therapy safety code?
Tumor immuno-gene therapy in terms of security, in general, should be better, a large number of clinical trials to prove this point, patients often receive treatment without significant adverse effects or mild side effects, such as transient fever , mild flu-like symptoms, most patients can tolerate these side effects often need to deal with that is able to relieve itself.
However, cell therapy safety risks still exist, and many come from man-made factors, such as whether the material used entirely to heat, the training process may lead to aseptic mishandled by cultured cells of various types of pathogenic micro-organisms pollution, some training may lead to the use of allogeneic serum of patients with allergy. Therefore, the cell culture conditions and environment, the process of cell preparation and standardization of strict quality control is very important.
In addition, some tumor-specific immunotherapy, such as tumor-specific T lymphocytes (CTL) for adoptive immunotherapy, DC vaccine, with its mechanism of action is to identify effector T cells by expression in tumor cells and tumor-associated antigen (in MHC-peptide complex form) while the tumor cells in vitro. Currently found in the vast majority of tumor-associated antigens are the body s own constituents, but under normal circumstances, normal tissue did not express or trace expression, or expression limited to a (few) tissue or cell type, and tumor cells overexpressing . Therefore, the existence of these immuno-gene therapy the risk of autoimmune reactions, although there have been studies conducted in various clinical trials has not been reported in patients with severe life-threatening autoimmune response, but a small number of patients with hypersensitivity constitution still more attention .
In short, any kind of new treatments is to be spread quickly and widely, there are two key criteria, namely, safety and efficacy. Tumor immune cell therapy as a relatively new cancer treatment, especially in recent years CIK and DC has been in clinical broader popularity, to a certain extent, these methods shows the safety and effectiveness. Of course, the integrated use of multiple methods of cancer treatment is the best model. World Health Organization has defined the tumor as a way to control chronic diseases, cancer immuno-gene therapy in improving survival of patients treated, extended periods of time, "survival zone" has a unique advantage, the production of immune gene therapy for cancer treatment and even Rehabilitation opened a new era.
Foreign scientists study found that people die of pituitary hormone secretion will be automatically
Foreign scientists have found that death and produced by living organisms is called a "death hormone" substances.
Biologists on the octopus s test proved this point. After ovulation, the female octopus its sons and daughters once hatched, the female octopus in this life will come to an end. In order to reveal the secret, scientists have conducted studies, found that the octopus has a pair of glands behind the eye socket. This time it will to a certain glands secrete a chemical substance, resulting in octopus own death. Biologists call this chemical as a "death hormone."
Human beings have no such "death of the glands" mean? After the study found that a human "death of the gland" long in the human brain is the pituitary gland. Although it is only 5 grams, but regulation, control of human growth and development, reproduction and metabolism, it is important to promote the secretion of thyroid hormone. Once thyroid hormone secretion stops, people will failure. Scientists study shows that human pituitary also regularly release "death hormone." "Death hormone" affect people s lives a normal life, to drive people to death.
Scientists now want to find out is: "death hormone" is what the cells of the pituitary gland? Through what channels to play its role? Its molecular structure is? What factors can make the "death hormone" to reduce or even stop the secretion? These problems are resolved, mankind can use drugs, surgery and other modern medical technology to destroy the "death hormone" produced, or delay its appearance, thus making the life is extended. (China Economic Net)
Germany developed high precision laser tomography
Saarland University, Germany issued a statement on the 21st, said researchers developed the school can be observed within a single cell of a new high-precision laser tomography can be used to test the effect of anti-aging products and to distinguish skin cancer lesions.
Koenig said the inventor of the instrument, the instrument s higher resolution than traditional ultrasound devices thousands of times, it is not only able to observe single cells, mitochondria can be observed even so. With this instrument can test out the sunscreen and other anti-aging products are effective. It also can be used to test the nicotine, hormones and other drugs effects of aging on the skin.
In addition, cancer cells in the laser irradiation will be brighter than healthy cells, doctors can use this instrument to provide three-dimensional images of patients with skin cancer to determine how cancerous skin cells, without removing the patient tissue for analysis.
South Korean scientists create world s smallest nano pump
An international research team recently reported that the use of nanotechnology to create the world s smallest liquid pump, only the equivalent of a human red blood cells in the blood so much, can be used to control the extremely small amount of liquid to transport drugs in a single cell.
New issue of the British "Nature Nanotechnology" magazine reported that the nano-pump is Korean and U.S. researchers have made. They use laser etched on the glass pipe tiny aperture, but the other end of the pipe leaving a very thin glass wall, and then did not penetrate the glass tube to the perfusion fluid conductive, making it on a nanoscale "wires." In a strong electric field applied under the conditions did not penetrate the end of the thin-walled glass tube will become able to conduct electricity, so can be used as electrodes.
By assembling these tiny "electronic equipment", the researchers create a nano-sized red blood cells is only a pump, it can control the liquid flow in liters per second quadrillionth.
The researchers said that this pump can be used for nano-infected cells from the small amount of liquid samples taken, or delivering drugs to individual cells. In addition, many for micro-fluid control device is using the glass material, this study used the technique of laser etching glass can also be used to improve existing relevant devices.